Transposition of the Great Arteries: Newborn Circulation and Life After Repair

Direct answer. In the dextro-transposition pattern discussed here, the aorta leaves the right ventricle and the pulmonary artery leaves the left. This creates parallel circulations, so a newborn needs adequate mixing and urgent specialist care. Arterial-switch and atrial-switch operations produce different anatomy and later follow-up concerns. Confidence is high in these distinctions; detailed intervention criteria and financially cleared outcome comparisons are not established here. GOSH transposition and parallel circulation anatomy.

Key takeaways
  • Parallel circulation prevents the usual sequence of lungs then body.
  • The amount of mixing and accompanying anatomy affect early oxygen delivery.
  • Newborn low oxygen or severe deterioration needs urgent specialist assessment.
  • An arterial switch and a Mustard/Senning atrial switch have different long-term issues.
  • The operation record matters for adult care, pregnancy and future procedures.

Evidence summary

QuestionSource roleConclusion and confidence
What is connected differently?Anatomical educationAorta to right ventricle; pulmonary artery to left. High confidence.
Why can a newborn deteriorate?Parallel-circuit mechanismThe body needs oxygenated blood to reach its circulation through adequate mixing.
Are both switch operations the same?Operation-specific educationNo. Arterial reconnection and atrial flow redirection have different anatomy.
Does childhood intervention end care?Adult congenital frameworkNo. Follow-up depends on the operation and current physiology.

Confidence is high in the condition distinctions and need for appropriate assessment. The treatment section attributes clinical guidance; it does not certify the funding of every underlying intervention trial. Independent comparative outcome certainty and a supplement replacement regimen were not established by this focused review. A public institution or independent review cannot make a sponsored original trial financially independent.

What it is

In a usual circulation, the right ventricle sends blood to the lungs and the left sends oxygenated blood to the body. In the transposition anatomy covered by this article, those great-vessel connections are reversed. Blood returning from the body can be sent back to the body, while blood returning from the lungs can be sent back to the lungs. GOSH transposition and parallel circulation anatomy.

The assessment must identify accompanying openings, outflow findings and other structures as well as name the transposition. A report and operation record should state the exact anatomy. A ventricular opening or other route of mixing can change early physiology, but its presence does not by itself establish a safe circulation or a complete treatment plan. NHLBI congenital anatomy and condition taxonomy, March2022; NHLBI congenital investigation education, March2022.

How it works

The main problem is the separation into parallel circuits rather than a normal continuous route through lungs and body. Mixing permits some oxygenated blood to reach the systemic circulation. The neonatal team assesses that mixing and the baby’s stability, not simply the vessel names or an isolated consumer oxygen reading. GOSH transposition and parallel circulation anatomy.

Selected early support includes maintaining ductal patency and a catheter procedure that improves mixing across the atrial septum. These are clinician-led measures for the actual circulation, not general treatments for all congenital defects. A drug used elsewhere to encourage duct closure cannot be transferred to this situation without considering why the duct is being kept open. Leeds TGA arterial-switch anatomy and later concerns, June2025.

Prenatal imaging can detect some congenital defects, while others are recognized after birth. A previous reassuring scan does not make newborn blue/grey colour, severe breathing difficulty or reduced responsiveness safe to dismiss. Confirming the anatomy promptly matters more than attempting to diagnose a specific defect from colour or feeding alone. NHLBI congenital screening and prevention limits, March2022; NHS congenital heart disease national guidance, December2025.

The evidence-based treatments

The arterial-switch operation reconnects the great arteries to restore the intended outflow relationship and includes transfer of the coronary arteries. The precise plan depends on anatomy and clinical circumstances. This guide does not give a fixed operation age, claim a uniform risk or provide a technical procedure recommendation for a particular baby. Leeds TGA arterial-switch anatomy and later concerns, June2025.

An atrial switch, termed Mustard or Senning according to the procedure, redirects venous flow through atrial channels or baffles. It leaves the anatomical right ventricle supporting the systemic circulation. That is a different arrangement from an arterial switch and cannot be summarized accurately by saying that the arteries were simply put back in their usual places. Leeds TGA atrial-switch and systemic-right-ventricle care, June2025.

After an arterial switch, review can address pulmonary outflow, the new aortic valve and root, ventricular function and coronary concerns. Following an atrial switch, review can address systemic-right-ventricle function, fast or slow rhythms and baffle narrowing or leakage. A new symptom therefore needs assessment using the actual operation rather than a generic “TGA repaired” label. Leeds TGA arterial-switch anatomy and later concerns, June2025; Leeds TGA atrial-switch and systemic-right-ventricle care, June2025.

Later medicines, catheter procedures, surgery or rhythm devices are selected for an established problem. They are not automatic parts of every adult’s care. The actual2025 AHA summary supports specialized congenital review, but the full joint guideline and author declarations were inaccessible. Its recommendations remain C-provisional context, with institutional corporate routes and original-trial financial gaps disclosed. AHA original2025 adult congenital guideline summary.

Supplement and lifestyle evidence

Activity should be tailored to current function, rhythm and operation-related findings. General heart-health habits complement rather than replace congenital follow-up. A manageable activity plan, psychological support and reliable access to care are more useful than a universal sports ban or a promise of no limitations. Pregnancy and contraception planning should review the actual circulation and medicines, particularly when systemic ventricular function is a concern. NHLBI lifelong congenital follow-up, March2022; NHLBI congenital pregnancy and medicine review, March2022.

No supplement is established here as a treatment for transposition of the great arteries. “Heart support,” improved vessel relaxation, a changed blood marker and fewer clinical events are different claims. The cited source set does not provide a fully financially screened trial basis for replacing diagnosis or prescribed care. Correcting a clinician-confirmed deficiency is a separate indication; a retail blend is not a diagnostic test or an emergency treatment.

What works and what does not

Useful transposition care identifies which circulation and repair are present before recommending treatment. It separates the newborn goal of adequate oxygen delivery from later questions about ventricles, valves, coronary arteries, baffles and rhythm. A previous successful intervention and normal daily functioning do not prove that every current finding is ordinary. Conversely, an operation-specific risk does not mean every patient will develop that complication.

Ask which outcome is being pursued: symptoms, physiological findings, recurrence, hospital admission or survival. A plan should also say how adverse effects and deterioration will be recognized. Personal stories and before-and-after readings cannot separate treatment effects from the natural course, other medicines or selection of patients. Manufacturer or materially conflicted outcome claims do not determine this article’s independent verdict.

Risks and side effects

A newborn or child who is blue/grey, severely breathless, limp, collapsed or less responsive needs emergency help. In an adult with previous transposition surgery, collapse, palpitations with major symptoms, sudden breathlessness or concerning chest pain also requires urgent assessment. Inform emergency clinicians of the congenital anatomy and operation if known, without delaying care to locate records. NHS congenital heart disease national guidance, December2025.

Early stabilization and cardiac surgery have risks; later residual or acquired findings differ between procedures. Baffle problems, systemic ventricular dysfunction or rhythm abnormalities after an atrial switch should not be confused with arterial-switch coronary or outflow concerns. Not every complication is inevitable. The team should explain applicable procedure risks and remaining uncertainty without borrowing a general recovery or success percentage. NHLBI congenital procedure background, March2022; NHLBI lifelong congenital follow-up, March2022.

Important interactions

Coordinate the full medicine and supplement list with the congenital team and pharmacist. A standard adult heart-failure or rhythm regimen may need review in a different congenital circulation. Pregnancy, organ function and existing devices can change choices. A dental-antibiotic decision or anticoagulant plan should state the actual indication; the diagnosis alone is not a universal prescription. NHLBI congenital procedure background, March2022; NHLBI congenital pregnancy and medicine review, March2022.

Bring prescription medicines, non-prescription products, recreational drugs and supplements to the same medication review. Product names alone may hide several active ingredients. The prescriber or pharmacist should check the exact combination and kidney function, rather than treating “natural” as a safety category. Never add a second person’s rescue medicine or stop an important prescribed medicine because an internet list mentions a possible interaction.

Who needs assessment

Anatomy, the operation report, current circulation and symptoms should guide assessment. Selected imaging and rhythm investigations answer different questions; a routine normal ECG cannot describe every coronary, valve or baffle feature. For an adult, childhood records and the current congenital specialist review help other clinicians interpret a new heart-failure or rhythm problem. NHLBI congenital investigation education, March2022; AHA original2025 congenital patient messages.

Pregnancy and contraception planning should use the actual anatomy, current function and medicine list. A childhood repair label alone cannot establish present safety. Clinical genetic counselling may be appropriate when the question is defined; an inconclusive or negative result does not settle all congenital risk. NHLBI congenital pregnancy and medicine review, March2022.

Clinician-led use and follow-up

Keep a concise record of the anatomical diagnosis, switch operation, subsequent procedures and implanted devices. Ask which findings are followed and how new palpitations, exertional change or breathlessness should be reported. Transition to adult care should transfer this detail, with specialist coordination before relevant pregnancy or other procedures. This article does not infer a fixed imaging schedule from an inaccessible full guideline. AHA original2025 congenital patient messages.

This guide gives no personal drug, device or supplement dose. The appropriate plan depends on the established diagnosis, current stability, other illnesses and local services. Ask for a written explanation of the treatment purpose, warning signs, review schedule and contact route for side effects. Clinical monitoring and informed consent should accompany any change; study exposures are not prescriptions.

Animal and in-vitro evidence

Animal and cellular studies of heart development can investigate mechanisms and candidate genes. They cannot establish a safe human supplement regimen, prove that a structural defect will close, or select an operation for a child or adult. Models may differ substantially from a person’s congenital anatomy and circulation. No animal or in-vitro result contributes to the independent clinical verdict in this guide.

Funding and source roles

Follow the money

Who paid for the evidence?

Follow named sources to the funding and relationships disclosed in this article. Numbered article disclosures preserve notes where a source is not identified. A public or university name alone does not establish independence.

Public / academicCommercial support or tiesUnknown / not disclosed
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Congenital definition and varied severity.
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Contributors and frequent uncertainty; no attribution of individual parental blame.
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Dated symptom education, not a diagnostic screen.
View 20 more funding disclosures
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Anatomy, rhythm and selected investigation context.
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Dated medicine/procedure background; no universal closure or transplant rule.
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Age-appropriate long-term care and activity.
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Individual reproductive and medication assessment.
Disclosed funding & relationshipsDHSC funds the national NHS website; its policy states no advertising or corporate sponsorship. Named authors, page-level budget and full underlying trial conflicts unresolved.
Use & limitsB provisional. Public-service remit and editorial checks support accuracy; simplification, service priorities and incomplete trial-finance tracing limit inference. Role: December2025 current national condition and emergency education.
Disclosed funding & relationshipsAHA donations, events, bequests and training revenue; 2024–25 report names BMS, Cytokinetics, Novartis and Stryker institutional support. Direct summary funding and joint guideline author/trial chain unresolved.
Use & limitsC provisional. Actual society summary opened, not the full guideline or author disclosures. Professional expertise supports attributed care context; corporate relationships and untraced original trials preclude independent efficacy clearance. Role: December2025 transition and specialist-care messages, C-provisional clinical context.
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Congenital transposition taxonomy.
Disclosed funding & relationshipsGOSH NHS Foundation Trust’s 2025–26 audited accounts identify NHS commissioner income, private-patient income, research income and charitable capital/expenditure contributions; its overview also names commercial research. Actual clinical-page allocation, research sponsors and author financial chain remain unresolved. The national NHS website sponsorship policy is not assumed to cover this separate Trust site.
Use & limitsB provisional for pediatric clinical context. Specialist public-service expertise supports accuracy; service incentives, age scope and unresolved donor or author ties limit inference. Role: Anatomical connections and parallel circuits.
Disclosed funding & relationshipsSeparate NHS Trust: commissioner, private-patient, research/training and charitable routes. 2025–26 accounts. Page budget and author/trial financial chain unresolved.
Use & limitsB provisional for clinical education. Specialist expertise and named review dates aid checking; service incentives and untraced author/device-study interests remain. Local outcome numbers and fixed medicine regimens are not used. Role: June2025 mixing support, coronary transfer and arterial-switch follow-up.
Disclosed funding & relationshipsSeparate NHS Trust: commissioner, private-patient, research/training and charitable routes. 2025–26 accounts. Page budget and author/trial financial chain unresolved.
Use & limitsB provisional for clinical education. Specialist expertise and named review dates aid checking; service incentives and untraced author/device-study interests remain. Local outcome numbers and fixed medicine regimens are not used. Role: June2025 systemic right ventricle, rhythm and baffle follow-up.
Disclosed funding & relationshipsAHA donations, events, bequests and training revenue; 2024–25 report names BMS, Cytokinetics, Novartis and Stryker institutional support. Direct summary funding and joint guideline author/trial chain unresolved.
Use & limitsC provisional. Actual society summary opened, not the full guideline or author disclosures. Professional expertise supports attributed care context; corporate relationships and untraced original trials preclude independent efficacy clearance. Role: C current adult congenital-care framework; full guideline inaccessible.
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Additional original linked in condition-specific education or follow-up.
Source / disclosureNHLBI budget
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Direct public financial policy, with legal accountability; actual gift donors and allocations not audited. Financial provenance only.
Source / disclosureNHLBI Gift Fund
Disclosed funding & relationshipsUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.
Use & limitsB provisional. Direct public financial policy, with legal accountability; actual gift donors and allocations not audited. Financial provenance only.
Disclosed funding & relationshipsDHSC funds the national NHS website; its policy states no advertising or corporate sponsorship. Named authors, page-level budget and full underlying trial conflicts unresolved.
Use & limitsB provisional. Explicit funding policy; actual individual declarations and implementation not audited. Financial provenance only.
Disclosed funding & relationshipsGOSH NHS Foundation Trust’s 2025–26 audited accounts identify NHS commissioner income, private-patient income, research income and charitable capital/expenditure contributions; its overview also names commercial research. Actual clinical-page allocation, research sponsors and author financial chain remain unresolved. The national NHS website sponsorship policy is not assumed to cover this separate Trust site.
Use & limitsB provisional. Audited institution accounts support stated revenue routes; page-level allocation, donors and all research sponsors were not cleared. Financial provenance only.
Disclosed funding & relationshipsSeparate NHS Trust: commissioner, private-patient, research/training and charitable routes. 2025–26 accounts. Page budget and author/trial financial chain unresolved.
Use & limitsB provisional. Audited accounts and published institution location support provenance; clinical-page allocation, full sponsor chain and author independence not cleared. Financial provenance only.
Disclosed funding & relationshipsSeparate NHS Trust: commissioner, private-patient, research/training and charitable routes. 2025–26 accounts. Page budget and author/trial financial chain unresolved.
Use & limitsB provisional. Audited accounts and published institution location support provenance; clinical-page allocation, full sponsor chain and author independence not cleared. Financial provenance only.
Disclosed funding & relationshipsAHA donations, events, bequests and training revenue; 2024–25 report names BMS, Cytokinetics, Novartis and Stryker institutional support. Direct summary funding and joint guideline author/trial chain unresolved.
Use & limitsB provisional for named revenue, support and location; C for certifying independence. AHA is financially interested in its own institutional account; direct clinical-page support and all partner-society finances unresolved. Financial provenance only.
Disclosed funding & relationshipsAHA donations, events, bequests and training revenue; 2024–25 report names BMS, Cytokinetics, Novartis and Stryker institutional support. Direct summary funding and joint guideline author/trial chain unresolved.
Use & limitsB provisional for named revenue, support and location; C for certifying independence. AHA is financially interested in its own institutional account; direct clinical-page support and all partner-society finances unresolved. Financial provenance only.

This graphic reorganizes the article's disclosures; it is not a new financial audit or independence classification. Highlighted notes show different funding relationships where available. Review funding is separate from underlying trial funding. Disclosure is not proof of falsehood, and no declared conflict is not proof of complete independence.

Financial interests include specialist imaging, genomic testing, pediatric and adult congenital services, medicines, occluders, conduits and valve implants. Institutional public funding does not clear individual research sponsors. The actual funding routes and unresolved author/trial chain are shown source by source. Manufacturer or materially conflicted clinical outcomes do not determine this article’s independent verdict.

The condition has no corporate owner. Medicines, diagnostics, devices, procedures and marketed supplements create different revenue incentives. This describes financial interests rather than misconduct. Funding tier evaluates proximity to the subject; A–D credibility assesses transparency, accuracy incentives and remaining uncertainty. An unresolved link stays unresolved, and a provisional public-information label does not clear the trials behind it.

SourceFunding / backersCountry / jurisdictionIndependenceCredibility / incentives / gaps
NHLBI congenital heart defects overview, March2022US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 1 public education provisionally; donation route and page-specific chain unresolved.B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Congenital definition and varied severity.
NHLBI congenital contributors and unresolved causes, March2022US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 1 public education provisionally; donation route and page-specific chain unresolved.B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Contributors and frequent uncertainty; no attribution of individual parental blame.
NHLBI congenital symptom education, March2022US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 1 public education provisionally; donation route and page-specific chain unresolved.B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Dated symptom education, not a diagnostic screen.
NHLBI congenital investigation education, March2022US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 1 public education provisionally; donation route and page-specific chain unresolved.B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Anatomy, rhythm and selected investigation context.
NHLBI congenital procedure background, March2022US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 1 public education provisionally; donation route and page-specific chain unresolved.B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Dated medicine/procedure background; no universal closure or transplant rule.
NHLBI lifelong congenital follow-up, March2022US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 1 public education provisionally; donation route and page-specific chain unresolved.B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Age-appropriate long-term care and activity.
NHLBI congenital pregnancy and medicine review, March2022US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 1 public education provisionally; donation route and page-specific chain unresolved.B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Individual reproductive and medication assessment.
NHS congenital heart disease national guidance, December2025DHSC funds the national NHS website; its policy states no advertising or corporate sponsorship. Named authors, page-level budget and full underlying trial conflicts unresolved.United Kingdom; England national public-information service. Other jurisdictions have different services.Tier 1 public education provisional; not a clearance of original studies.B provisional. Public-service remit and editorial checks support accuracy; simplification, service priorities and incomplete trial-finance tracing limit inference. Role: December2025 current national condition and emergency education.
AHA original2025 congenital patient messagesAHA donations, events, bequests and training revenue; 2024–25 report names BMS, Cytokinetics, Novartis and Stryker institutional support. Direct summary funding and joint guideline author/trial chain unresolved.United States; AHA National Center, Dallas, Texas. Joint professional guidance is multinational; commercial supporter manufacturing origin not traced.Tier 2 society with relevant drug/device institutional revenue; author chain unresolved.C provisional. Actual society summary opened, not the full guideline or author disclosures. Professional expertise supports attributed care context; corporate relationships and untraced original trials preclude independent efficacy clearance. Role: December2025 transition and specialist-care messages, C-provisional clinical context.
NHLBI congenital anatomy and condition taxonomy, March2022US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 1 public education provisionally; donation route and page-specific chain unresolved.B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Congenital transposition taxonomy.
GOSH transposition and parallel circulation anatomyGOSH NHS Foundation Trust’s 2025–26 audited accounts identify NHS commissioner income, private-patient income, research income and charitable capital/expenditure contributions; its overview also names commercial research. Actual clinical-page allocation, research sponsors and author financial chain remain unresolved. The national NHS website sponsorship policy is not assumed to cover this separate Trust site.United Kingdom; Great Ormond Street Hospital for Children NHS Foundation Trust, London; pediatric public provider.Tier 2 institutional service-fee/charity routes; full chain provisional.B provisional for pediatric clinical context. Specialist public-service expertise supports accuracy; service incentives, age scope and unresolved donor or author ties limit inference. Role: Anatomical connections and parallel circuits.
Leeds TGA arterial-switch anatomy and later concerns, June2025Separate NHS Trust: commissioner, private-patient, research/training and charitable routes. 2025–26 accounts. Page budget and author/trial financial chain unresolved.United Kingdom; Leeds Teaching Hospitals NHS Trust, Leeds, England. Local specialist pathway; not national NHS website finance.Tier 2 provider and charity/service routes, provisional; commercial research documented.B provisional for clinical education. Specialist expertise and named review dates aid checking; service incentives and untraced author/device-study interests remain. Local outcome numbers and fixed medicine regimens are not used. Role: June2025 mixing support, coronary transfer and arterial-switch follow-up.
Leeds TGA atrial-switch and systemic-right-ventricle care, June2025Separate NHS Trust: commissioner, private-patient, research/training and charitable routes. 2025–26 accounts. Page budget and author/trial financial chain unresolved.United Kingdom; Leeds Teaching Hospitals NHS Trust, Leeds, England. Local specialist pathway; not national NHS website finance.Tier 2 provider and charity/service routes, provisional; commercial research documented.B provisional for clinical education. Specialist expertise and named review dates aid checking; service incentives and untraced author/device-study interests remain. Local outcome numbers and fixed medicine regimens are not used. Role: June2025 systemic right ventricle, rhythm and baffle follow-up.
AHA original2025 adult congenital guideline summaryAHA donations, events, bequests and training revenue; 2024–25 report names BMS, Cytokinetics, Novartis and Stryker institutional support. Direct summary funding and joint guideline author/trial chain unresolved.United States; AHA National Center, Dallas, Texas. Joint professional guidance is multinational; commercial supporter manufacturing origin not traced.Tier 2 society with relevant drug/device institutional revenue; author chain unresolved.C provisional. Actual society summary opened, not the full guideline or author disclosures. Professional expertise supports attributed care context; corporate relationships and untraced original trials preclude independent efficacy clearance. Role: C current adult congenital-care framework; full guideline inaccessible.
NHLBI congenital screening and prevention limits, March2022US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 1 public education provisionally; donation route and page-specific chain unresolved.B provisional. Public accountability and educational review favour accuracy; institutional priorities, simplification, dated wording and untraced trial ties remain. Role: Additional original linked in condition-specific education or follow-up.
NHLBI budgetUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 3 institutional financial self-disclosure.B provisional. Direct public financial policy, with legal accountability; actual gift donors and allocations not audited. Financial provenance only.
NHLBI Gift FundUS federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved.United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction.Tier 3 institutional financial self-disclosure.B provisional. Direct public financial policy, with legal accountability; actual gift donors and allocations not audited. Financial provenance only.
NHS national website funding policyDHSC funds the national NHS website; its policy states no advertising or corporate sponsorship. Named authors, page-level budget and full underlying trial conflicts unresolved.United Kingdom; England national public-information service. Other jurisdictions have different services.Tier 3 editorial and financial self-disclosure.B provisional. Explicit funding policy; actual individual declarations and implementation not audited. Financial provenance only.
GOSH audited annual accounts 2025–26GOSH NHS Foundation Trust’s 2025–26 audited accounts identify NHS commissioner income, private-patient income, research income and charitable capital/expenditure contributions; its overview also names commercial research. Actual clinical-page allocation, research sponsors and author financial chain remain unresolved. The national NHS website sponsorship policy is not assumed to cover this separate Trust site.United Kingdom; Great Ormond Street Hospital for Children NHS Foundation Trust, London; pediatric public provider.Tier 3 Trust financial self-disclosure.B provisional. Audited institution accounts support stated revenue routes; page-level allocation, donors and all research sponsors were not cleared. Financial provenance only.
Leeds Teaching Hospitals audited2025–26 accountsSeparate NHS Trust: commissioner, private-patient, research/training and charitable routes. 2025–26 accounts. Page budget and author/trial financial chain unresolved.United Kingdom; Leeds Teaching Hospitals NHS Trust, Leeds, England. Local specialist pathway; not national NHS website finance.Tier 3 institution financial/contact self-disclosure.B provisional. Audited accounts and published institution location support provenance; clinical-page allocation, full sponsor chain and author independence not cleared. Financial provenance only.
Leeds2026 annual report publication and institution locationSeparate NHS Trust: commissioner, private-patient, research/training and charitable routes. 2025–26 accounts. Page budget and author/trial financial chain unresolved.United Kingdom; Leeds Teaching Hospitals NHS Trust, Leeds, England. Local specialist pathway; not national NHS website finance.Tier 3 institution financial/contact self-disclosure.B provisional. Audited accounts and published institution location support provenance; clinical-page allocation, full sponsor chain and author independence not cleared. Financial provenance only.
AHA2024–25 annual report and named corporate supportAHA donations, events, bequests and training revenue; 2024–25 report names BMS, Cytokinetics, Novartis and Stryker institutional support. Direct summary funding and joint guideline author/trial chain unresolved.United States; AHA National Center, Dallas, Texas. Joint professional guidance is multinational; commercial supporter manufacturing origin not traced.Tier 3 institutional financial/contact self-disclosure.B provisional for named revenue, support and location; C for certifying independence. AHA is financially interested in its own institutional account; direct clinical-page support and all partner-society finances unresolved. Financial provenance only.
AHA National Center Dallas contactAHA donations, events, bequests and training revenue; 2024–25 report names BMS, Cytokinetics, Novartis and Stryker institutional support. Direct summary funding and joint guideline author/trial chain unresolved.United States; AHA National Center, Dallas, Texas. Joint professional guidance is multinational; commercial supporter manufacturing origin not traced.Tier 3 institutional financial/contact self-disclosure.B provisional for named revenue, support and location; C for certifying independence. AHA is financially interested in its own institutional account; direct clinical-page support and all partner-society finances unresolved. Financial provenance only.

Frequently asked questions

Why is mixing important initially? Parallel circuits need a route for oxygenated blood to reach the body. GOSH transposition and parallel circulation anatomy.

Are arterial and atrial switches identical? No. One reconnects great-vessel outflow; the other redirects atrial blood flow. Leeds TGA arterial-switch anatomy and later concerns, June2025; Leeds TGA atrial-switch and systemic-right-ventricle care, June2025.

Can an adult need care after a childhood operation? Yes. Current function, valves, coronary or baffle findings and rhythm need operation-specific assessment.

Does a reassuring prenatal scan exclude the condition? Congenital screening does not identify every defect. New concerning symptoms need assessment. NHLBI congenital screening and prevention limits, March2022.

Sources and funding notes

Original clinical pages and their relevant financial disclosures were opened. Actual December2025 AHA adult-congenital summaries and patient messages were read. The full2025 ACC/AHA/HRS/ISACHD/SCAI guideline, author-declaration chain and slide download were blocked and were not read. No complete guideline assessment or numeric intervention criterion is inferred from the summaries. AHA2024–25 institutional financial disclosures and Dallas contact were checked; joint-society finances and direct page allocation remain unresolved. Institutional corporate funding is not assumed to fund this particular document. These summaries are attributed C-provisional clinical context, excluded from the independent efficacy verdict. Leeds Teaching Hospitals2025–26 original audited accounts were read separately from national NHS policy. Clinical leaflet review dates are source-specific and do not establish that every cited study was updated. Local procedure rates, fixed antithrombotic doses and recovery promises are not imported as independent evidence or personal instructions. Public clinical sources concentrate on US and English services; referral and treatment availability vary by jurisdiction. Guidance, classification, emergency education and independent efficacy are distinct source roles. A full systematic review, complete society donor audit and author-by-author clearance of original treatment trials were not completed.

Last reviewed: October 4, 2026. Educational information, not a diagnosis or personal treatment plan. Use your local emergency service for an emergency.

Have a question — or want us to cover something?

Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.

We store your topic, message, optional email, and this page so we can manage and reply to the request. Do not include diagnoses, medications, or other sensitive medical information. See our Privacy Policy.